Epsilon working with ASX as two-year suspension deadline approaches by Adam Sheldon December 9, 2025December 10, 2025 Epsilon Healthcare said it was working “constructively” with the ASX to return to the market, as […]
Package goods executive named MD of MedReleaf Australia by Steve Jones December 9, 2025February 21, 2026
Federal Court backs funding bid as liquidators pursue $22m owed to Melodiol creditors by Adam Sheldon December 8, 2025February 21, 2026
Cann Group set for ‘stronger future’ after ‘challenging period’, outgoing chair tells shareholders by Steve Jones December 4, 2025February 21, 2026
AMCA chair delivers impassioned defence of medicinal cannabis amid regulatory reform threat by Steve Jones December 4, 2025December 4, 2025
‘Totally disproportionate’: Welsh to appeal after prescribing ban upheld by Adam Sheldon December 4, 2025December 4, 2025
Altum calls on prescribers to ‘back compliant firms’ after losses double by Steve Jones December 3, 2025December 4, 2025
AP approvals fall as medicinal cannabis sales plateau, Penington report finds by Adam Sheldon December 3, 2025December 4, 2025
Cannim gets stay of execution as potential buyer moves in by Steve Jones December 3, 2025December 4, 2025
Elixinol names new chair in pursuit of ‘sustainable and profitable business’ by Steve Jones December 2, 2025February 21, 2026
